Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 0 Trials for Cyclophosphamide (DB00531)
Indication | Status | Phase |
---|---|---|
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma) | Completed | 0 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01959477 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | Treatment |